Published in J Am Soc Nephrol on January 24, 2013
COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. J Am Soc Nephrol (2013) 1.16
Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment. J Physiol (2014) 0.97
Natural history of genetically proven autosomal recessive Alport syndrome. Pediatr Nephrol (2014) 0.96
Ocular features in Alport syndrome: pathogenesis and clinical significance. Clin J Am Soc Nephrol (2015) 0.94
A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers. Kidney Int (2014) 0.93
The 2014International Workshop on Alport Syndrome. Kidney Int (2014) 0.89
The prevalence and epidemiology of genetic renal disease amongst adults with chronic kidney disease in Australia. Orphanet J Rare Dis (2014) 0.83
Clinical utility gene card for: Alport syndrome - update 2014. Eur J Hum Genet (2014) 0.81
Alport Syndrome in Women and Girls. Clin J Am Soc Nephrol (2016) 0.81
A COL4A5 mutation with glomerular disease and signs of chronic thrombotic microangiopathy. Clin Kidney J (2015) 0.79
A female with X-linked Alport syndrome and compound heterozygous COL4A5 mutations. Pediatr Nephrol (2013) 0.78
Coinheritance of COL4A5 and MYO1E mutations accentuate the severity of kidney disease. Pediatr Nephrol (2015) 0.78
Podocyte Depletion in Thin GBM and Alport Syndrome. PLoS One (2016) 0.77
Three-dimensional electron microscopy reveals the evolution of glomerular barrier injury. Sci Rep (2016) 0.77
Genetic testing can resolve diagnostic confusion in Alport syndrome. Clin Kidney J (2013) 0.77
Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutations. Pediatr Nephrol (2016) 0.77
X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations. PLoS One (2016) 0.76
Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy. Pediatr Nephrol (2016) 0.75
Alport syndrome: facts and opinions. F1000Res (2017) 0.75
Whole exome sequencing reveals novel COL4A3 and COL4A4 mutations and resolves diagnosis in Chinese families with kidney disease. BMC Nephrol (2014) 0.75
Somatic mosaicism and variant frequency detected by next-generation sequencing in X-linked Alport syndrome. Eur J Hum Genet (2015) 0.75
X-Linked Alport Dogs Demonstrate Mesangial Filopodial Invasion of the Capillary Tuft as an Early Event in Glomerular Damage. PLoS One (2016) 0.75
Two Pregnancies with a Different Outcome in a Patient with Alport Syndrome. Open Access Maced J Med Sci (2016) 0.75
The Challenges of Diagnosing and Following Wilson Disease in the Presence of Proteinuria. Pediatr Gastroenterol Hepatol Nutr (2016) 0.75
The variable course of women with X-linked Alport Syndrome. Clin Kidney J (2013) 0.75
Efficient Targeted Next Generation Sequencing-Based Workflow for Differential Diagnosis of Alport-Related Disorders. PLoS One (2016) 0.75
A Novel Mutation in a Japanese Family with X-linked Alport Syndrome. Intern Med (2016) 0.75
Anti-Glomerular Basement Membrane Disease. Clin J Am Soc Nephrol (2017) 0.75
X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene. Clin Exp Nephrol (2015) 0.75
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation (2017) 0.75
The Variability of Estimated Glomerular Filtration Rate Decline in Alport Syndrome. Can J Kidney Health Dis (2016) 0.75
ARB: a software environment for sequence data. Nucleic Acids Res (2004) 58.27
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy. N Engl J Med (2015) 4.78
Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med (2010) 3.78
Melamine-contaminated powdered formula and urolithiasis in young children. N Engl J Med (2009) 3.46
Survival prediction of gastric cancer by a seven-microRNA signature. Gut (2009) 2.37
Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer. J Clin Oncol (2010) 2.16
X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study. J Am Soc Nephrol (2003) 2.12
miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res (2011) 2.00
MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology (2010) 1.88
Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer (2008) 1.88
Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations. Kidney Int (2012) 1.87
MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology (2010) 1.82
Use of ionic liquids for pi-conjugated polymer electrochemical devices. Science (2002) 1.66
Preimplantation genetic diagnosis. Nat Rev Genet (2002) 1.62
Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injury. Kidney Int (2011) 1.59
Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding. J Gastroenterol Hepatol (2012) 1.51
Over-expressing transient receptor potential cation channel 6 in podocytes induces cytoskeleton rearrangement through increases of intracellular Ca2+ and RhoA activation. Exp Biol Med (Maywood) (2011) 1.47
Up-regulation of tumor suppressor genes might promote the malignant phenotype of cancer cells. Med Hypotheses (2007) 1.39
Risk factors and treatment success for ureteral obstruction after pediatric renal transplantation. J Urol (2010) 1.39
Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology (2011) 1.36
Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol (2011) 1.36
Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res (2008) 1.36
Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height. Oncotarget (2011) 1.31
Refined genotype-phenotype correlations in cases of chromosome 6p deletion syndromes. Eur J Hum Genet (2004) 1.31
MicroRNA-550a acts as a pro-metastatic gene and directly targets cytoplasmic polyadenylation element-binding protein 4 in hepatocellular carcinoma. PLoS One (2012) 1.29
MicroRNA-181a modulates gene expression of zinc finger family members by directly targeting their coding regions. Nucleic Acids Res (2010) 1.29
Integration of ranked lists via cross entropy Monte Carlo with applications to mRNA and microRNA Studies. Biometrics (2008) 1.27
Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women. Int J Cancer (2008) 1.24
Estimation of sequencing error rates in short reads. BMC Bioinformatics (2012) 1.22
Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF. PLoS One (2012) 1.20
Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease. J Am Soc Nephrol (2005) 1.19
MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. Carcinogenesis (2011) 1.19
Molecular basis of therapeutic approaches to gastric cancer. J Gastroenterol Hepatol (2009) 1.18
Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative. Pediatr Nephrol (2012) 1.17
CoGAPS: an R/C++ package to identify patterns and biological process activity in transcriptomic data. Bioinformatics (2010) 1.15
Differential display of vincristine-resistance-related genes in gastric cancer SGC7901 cell. World J Gastroenterol (2002) 1.15
MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer. J Cell Mol Med (2011) 1.15
Characterizing ionic liquids on the basis of multiple solvation interactions. J Am Chem Soc (2002) 1.14
Alport syndrome--insights from basic and clinical research. Nat Rev Nephrol (2012) 1.14
Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease. Neurology (2012) 1.11
Visual impairment, age-related eye diseases, and cognitive function: the Singapore Malay Eye study. Arch Ophthalmol (2012) 1.10
The value of clinical criteria in identifying patients with X-linked Alport syndrome. Clin J Am Soc Nephrol (2010) 1.07
Stem cell therapy for Alport syndrome: the hope beyond the hype. Nephrol Dial Transplant (2008) 1.07
TRPC6 up-regulation in Ang II-induced podocyte apoptosis might result from ERK activation and NF-kappaB translocation. Exp Biol Med (Maywood) (2009) 1.07
Elimination of systematic mass measurement errors in liquid chromatography-mass spectrometry based proteomics using regression models and a priori partial knowledge of the sample content. Anal Chem (2007) 1.06
Direct effect of croton oil on intestinal epithelial cells and colonic smooth muscle cells. World J Gastroenterol (2002) 1.05
Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype. Am J Med Genet A (2013) 1.04
A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis. J Thorac Cardiovasc Surg (2011) 1.03
Structural and functional cerebral impairments in cirrhotic patients with a history of overt hepatic encephalopathy. Eur J Radiol (2011) 1.03
Human hypertrophic scar-like nude mouse model: characterization of the molecular and cellular biology of the scar process. Wound Repair Regen (2011) 0.98
The molecular mechanism of hypertrophic scar. J Cell Commun Signal (2013) 0.97
Optimising the incorporation and release of a neurotrophic factor using conducting polypyrrole. J Control Release (2006) 0.97
Human enterovirus 71 uncoating captured at atomic resolution. J Virol (2013) 0.97
Integrin α2-deficient mice provide insights into specific functions of collagen receptors in the kidney. Fibrogenesis Tissue Repair (2010) 0.96
Involvement of epidermal growth factor receptor overexpression in the promotion of breast cancer brain metastasis. Cancer (2012) 0.95
Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in non-inflammatory glomerular injury. J Pathol (2012) 0.95
Phenotypic features in patients with 15q11.2(BP1-BP2) deletion: further delineation of an emerging syndrome. Am J Med Genet A (2014) 0.95
Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab. Am J Kidney Dis (2010) 0.95
Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-α-mediated podocyte loss. Kidney Int (2010) 0.94
Optimization of culture conditions for hydrogen production by Ethanoligenens harbinense B49 using response surface methodology. Bioresour Technol (2008) 0.94
Effect of the knockdown of podocin mRNA on nephrin and alpha-actinin in mouse podocyte. Exp Biol Med (Maywood) (2004) 0.94
Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells. FEBS J (2009) 0.94
Clinical utility gene card for: Alport syndrome. Eur J Hum Genet (2011) 0.94
Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1. Lab Invest (2007) 0.94
Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. Hum Mutat (2005) 0.94
Reduction of TIP30 correlates with poor prognosis of gastric cancer patients and its restoration drastically inhibits tumor growth and metastasis. Int J Cancer (2009) 0.93
Retinal vessel caliber and lifelong neuropsychological functioning: retinal imaging as an investigative tool for cognitive epidemiology. Psychol Sci (2013) 0.93
Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome. Nephrol Dial Transplant (2007) 0.93
Antigen retrieval with protease digestion applied in immunohistochemical diagnosis of Alport syndrome. Nephrol Dial Transplant (2008) 0.93
MAD2 as a key component of mitotic checkpoint: A probable prognostic factor for gastric cancer. Am J Clin Pathol (2009) 0.92
GNAI1 Suppresses Tumor Cell Migration and Invasion and is Post-Transcriptionally Regulated by Mir-320a/c/d in Hepatocellular Carcinoma. Cancer Biol Med (2012) 0.92
Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes. J Am Soc Nephrol (2003) 0.92
Expression and significances of Id1 helix-loop-helix protein overexpression in gastric cancer. Cancer Lett (2004) 0.92
Detection of parent-of-origin effects using general pedigree data. Genet Epidemiol (2010) 0.92
Depression of MAD2 inhibits apoptosis and increases proliferation and multidrug resistance in gastric cancer cells by regulating the activation of phosphorylated survivin. Tumour Biol (2010) 0.92
Tumour necrosis factor-α drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis. J Pathol (2011) 0.92
Mutations in NPHS2 in sporadic steroid-resistant nephrotic syndrome in Chinese children. Nephrol Dial Transplant (2005) 0.92
Truncation of murine CaV1.2 at Asp-1904 results in heart failure after birth. J Biol Chem (2011) 0.91
Status of clinical research in China. Lancet (2011) 0.91
Hydrogen production with R. faecalis RLD-53 isolated from freshwater pond sludge. Bioresour Technol (2008) 0.91
Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar. Wound Repair Regen (2011) 0.91
Lithium triborate laser vaporization of the prostate using the 120 W, high performance system laser: high performance all the way? J Urol (2011) 0.91
Molecular testing for adult type Alport syndrome. BMC Nephrol (2009) 0.90
[Metabonomic study of syndrome of liver qi stagnation and spleen deficiency in rats]. Zhong Xi Yi Jie He Xue Bao (2007) 0.90
Fibrotic remodeling of tissue-engineered skin with deep dermal fibroblasts is reduced by keratinocytes. Tissue Eng Part A (2013) 0.90
DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome. Pediatr Nephrol (2013) 0.89
High Resolution Separations and Improved Ion Production and Transmission in Metabolomics. Trends Analyt Chem (2008) 0.89
The use of laser Doppler imaging as a predictor of burn depth and hypertrophic scar postburn injury. J Burn Care Res (2012) 0.88
Durable, self-healing superhydrophobic and superoleophobic surfaces from fluorinated-decyl polyhedral oligomeric silsesquioxane and hydrolyzed fluorinated alkyl silane. Angew Chem Int Ed Engl (2011) 0.88
Aortic abnormalities in males with Alport syndrome. Nephrol Dial Transplant (2010) 0.88
Newly identified cytoskeletal components are associated with dynamic changes of podocyte foot processes. Nephrol Dial Transplant (2009) 0.88
Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1. Int J Cancer (2005) 0.88